📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials. (2023)

First Author: Voysey M

Attributed to: nCoV: Rapid Clinical Development of ChAdOx1 nCoV-19 funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cei/uxad013

PubMed Identifier: 36729167

Publication URI: http://europepmc.org/abstract/MED/36729167

Type: Journal Article/Review

Volume: 211

Parent Publication: Clinical and experimental immunology

Issue: 3

ISSN: 0009-9104